• Je něco špatně v tomto záznamu ?

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

D. Timmerman, F. Planchamp, T. Bourne, C. Landolfo, A. du Bois, L. Chiva, D. Cibula, N. Concin, D. Fischerova, W. Froyman, G. Gallardo Madueño, B. Lemley, A. Loft, L. Mereu, P. Morice, D. Querleu, AC. Testa, I. Vergote, V. Vandecaveye, G....

. 2021 ; 31 (7) : 961-982. [pub] 20210610

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012364
E-zdroje Online Plný text

NLK ProQuest Central od 2018-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2018-01-01 do Před 6 měsíci

The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group, and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the pre-operative diagnosis of ovarian tumors, including imaging techniques, biomarkers, and prediction models. ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the pre-operative diagnosis of ovarian tumors and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when a consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements. This Consensus Statement presents these ESGO/ISUOG/IOTA/ESGE statements on the pre-operative diagnosis of ovarian tumors and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.

Clinical Physiology Nuclear Medicine and PET Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Clinical Research Unit Institut Bergonie Bordeaux France

Development and Regeneration KU Leuven Leuven Belgium

Division of Translational MRI Department of Imaging and Pathology KU Leuven Leuven Belgium

European Network of Gynaecological Cancers Advocacy Groups Executive Group Prague Czech Republic

Gynaecologic Oncology Hammersmith Hospital Imperial College London UK

Gynaecological Surgery Institut Gustave Roussy Villejuif France

Gynaecology and Gynaecological Oncology Evangelische Kliniken Essen Mitte Essen Germany

Gynaecology and Obstetrics University Clinic of Navarra Madrid Spain

Gynecologic Oncology Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy

Gynecology and Obstetrics Gynecologic Oncology Unit Santa Chiara Hospital Trento Italy

Gynecology and Obstetrics University Hospitals KU Leuven Leuven Belgium

KIU Patient Organisation for Women with Gynaecological Cancer Copenhagen Denmark

Metabolism Digestion and Reproduction Queen Charlotte's and Chelsea Hospital Imperial College London UK

Obstetrics and Gynaecology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Obstetrics and Gynaecology and Gynaecologic Oncology University Hospital Leuven Leuven Cancer Institute Leuven Belgium

Obstetrics and Gynecologic Oncology University Hospital Strasbourg France

Obstetrics and Gynecology Medical University of Innsbruck Innsbruck Austria

Obstetrics and Gynecology Università Cattolica del Sacro Cuore Rome Italy

Radiology University Clinic of Navarra Madrid Spain

Radiology University Hospitals Leuven Leuven Belgium

Woman Child and Public Health Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012364
003      
CZ-PrNML
005      
20240731105922.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/ijgc-2021-002565 $2 doi
035    __
$a (PubMed)34112736
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Timmerman, Dirk $u Gynecology and Obstetrics, University Hospitals KU Leuven, Leuven, Belgium Dirk.timmerman@uzleuven.be $u Development and Regeneration, KU Leuven, Leuven, Belgium $1 https://orcid.org/0000000237076645
245    10
$a ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors / $c D. Timmerman, F. Planchamp, T. Bourne, C. Landolfo, A. du Bois, L. Chiva, D. Cibula, N. Concin, D. Fischerova, W. Froyman, G. Gallardo Madueño, B. Lemley, A. Loft, L. Mereu, P. Morice, D. Querleu, AC. Testa, I. Vergote, V. Vandecaveye, G. Scambia, C. Fotopoulou
520    9_
$a The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group, and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the pre-operative diagnosis of ovarian tumors, including imaging techniques, biomarkers, and prediction models. ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the pre-operative diagnosis of ovarian tumors and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when a consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements. This Consensus Statement presents these ESGO/ISUOG/IOTA/ESGE statements on the pre-operative diagnosis of ovarian tumors and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.
650    _2
$a konsensus $7 D032921
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nádory vaječníků $x diagnóza $7 D010051
650    _2
$a předoperační období $7 D057234
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Planchamp, François $u Clinical Research Unit, Institut Bergonie, Bordeaux, France
700    1_
$a Bourne, Tom $u Gynecology and Obstetrics, University Hospitals KU Leuven, Leuven, Belgium $u Development and Regeneration, KU Leuven, Leuven, Belgium $u Metabolism Digestion and Reproduction, Queen Charlotte's & Chelsea Hospital, Imperial College, London, UK $1 https://orcid.org/0000000314216059
700    1_
$a Landolfo, Chiara $u Woman, Child and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy $1 https://orcid.org/0000000198087957
700    1_
$a Du Bois, Andreas, $d 1956- $u Gynaecology and Gynaecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany $7 xx0320625
700    1_
$a Chiva, Luis $u Gynaecology and Obstetrics, University Clinic of Navarra, Madrid, Spain $1 https://orcid.org/0000000219083251
700    1_
$a Cibula, David $u Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000163879356 $7 jo20000074072
700    1_
$a Concin, Nicole $u Gynaecology and Gynaecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany $u Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria $1 https://orcid.org/0000000297952643
700    1_
$a Fischerova, Daniela $u Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000272243218 $7 xx0074804
700    1_
$a Froyman, Wouter $u Gynecology and Obstetrics, University Hospitals KU Leuven, Leuven, Belgium $1 https://orcid.org/0000000213989124
700    1_
$a Gallardo Madueño, Guillermo $u Radiology, University Clinic of Navarra, Madrid, Spain $1 https://orcid.org/0000000275023544
700    1_
$a Lemley, Birthe $u European Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic $u KIU - Patient Organisation for Women with Gynaecological Cancer, Copenhagen, Denmark
700    1_
$a Loft, Annika $u Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
700    1_
$a Mereu, Liliana $u Gynecology and Obstetrics, Gynecologic Oncology Unit, Santa Chiara Hospital, Trento, Italy
700    1_
$a Morice, Philippe $u Gynaecological Surgery, Institut Gustave Roussy, Villejuif, France
700    1_
$a Querleu, Denis $u Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy $u Obstetrics and Gynecologic Oncology, University Hospital, Strasbourg, France $1 https://orcid.org/0000000239844812
700    1_
$a Testa, Antonia Carla $u Woman, Child and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy $u Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Rome, Italy $1 https://orcid.org/0000000322178726
700    1_
$a Vergote, Ignace $u Obstetrics and Gynaecology and Gynaecologic Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium
700    1_
$a Vandecaveye, Vincent $u Radiology, University Hospitals Leuven, Leuven, Belgium $u Division of Translational MRI, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium $1 https://orcid.org/0000000208003279
700    1_
$a Scambia, Giovanni $u Woman, Child and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy $u Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Rome, Italy
700    1_
$a Fotopoulou, Christina $u Gynaecologic Oncology, Hammersmith Hospital, Imperial College, London, UK $1 https://orcid.org/0000000163759645
773    0_
$w MED00009896 $t International journal of gynecological cancer $x 1525-1438 $g Roč. 31, č. 7 (2021), s. 961-982
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34112736 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20240731105920 $b ABA008
999    __
$a ok $b bmc $g 1789800 $s 1163565
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 31 $c 7 $d 961-982 $e 20210610 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...